The Rubicon Research IPO has entered its final day of bidding today, October 13. The public issue was opened on Thursday, October 9. Let’s take a look at the key factors to watch out for this issue –
Rubicon Research IPO: GMP trend
As of the latest, the unlisted shares of Rubicon Research were trading at a premium of Rs 95 in the grey market.
This translates into an estimated listing price of around Rs 580 per share, suggesting a potential gain of nearly 20% over the IPO’s upper price band of Rs 485.
However, GMP is not the official listing price and fluctuates based on market sentiment .
Rubicon Research IPO: Details and structure
Rubicon Research’s IPO is a Rs 1,377.50 crore book-built issue, comprising a fresh issue of Rs 500 crore and an offer-for-sale (OFS) worth Rs 877.50 crore.
The price band is fixed between Rs 461-485 per share. Retail investors can bid for a minimum of 30 shares per lot, requiring an investment of Rs 14,550, while larger non-institutional investors can opt for multiple lots.
Axis Capital is serving as the lead manager and MUFG Intime India handling the registrar duties.
Rubicon Research IPO: What’s next after the bidding closes
Once the subscription window shuts this evening, attention will shift to allotment and listing. The share allotment is likely to be finalised on October 14, with successful bidders set to receive shares in their demat accounts by October 15.
Refunds for non-allottees will also be processed the same day. The company’s shares are scheduled to debut on the NSE and BSE on October 16.
Rubicon Research IPO: Financials performance of the company
Rubicon Research profit after tax surged 47.6% year-on-year to Rs 134.36 crore in FY25, while total income rose 48.58% to Rs 1,296.22 crore.